EEG in Children With Unilateral Cerebral Injury During Action and Action Observation(AOE)

NCT ID: NCT02597374

Last Updated: 2022-07-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

15 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-10-31

Study Completion Date

2023-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To study the reactivity of the mu rhythm during action and action-observation by EEG in children with unilateral cerebral injury.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cerebral Palsy Child

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Experimental

A 45 mn EEG for all the participants.

Group Type EXPERIMENTAL

EEG

Intervention Type DEVICE

A 45 mn EEG will be performed in each participants during action and action observation of each hand.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

EEG

A 45 mn EEG will be performed in each participants during action and action observation of each hand.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* unilateral cerebral injury
* hemiplegia

Exclusion Criteria

* visual or mental or cognitive impairment
* no health insurance
Minimum Eligible Age

6 Years

Maximum Eligible Age

20 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital, Angers

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

NGUYEN THE TICH Sylvie, MD-PHD

Role: PRINCIPAL_INVESTIGATOR

University Hospital, Angers

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Chu Angers

Angers, , France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

NGUYEN THE TICH Sylvie, MD-PHD

Role: CONTACT

2-41-35-44-45 ext. 0033

DINOMAIS Mickaƫl, MD-PHD

Role: CONTACT

2-41-35-18-03 ext. 0033

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

MICKAEL DINOMAIS, MD-PHD

Role: primary

02 41 35 18 03

MAXIMILIEN PERIVIER

Role: backup

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CHU-Promoteur 2015-A00985-44

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.